Literature DB >> 32005652

Is unrelated donor or haploidentical hematopoietic transplantation preferred for patients with acute myeloid leukemia in remission?

Richard Champlin1.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32005652      PMCID: PMC7012488          DOI: 10.3324/haematol.2019.239624

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  25 in total

1.  Comparable survival after HLA-well-matched unrelated or matched sibling donor transplantation for acute myeloid leukemia in first remission with unfavorable cytogenetics at diagnosis.

Authors:  Vikas Gupta; Martin S Tallman; Wensheng He; Brent R Logan; Edward Copelan; Robert Peter Gale; Hanna J Khoury; Thomas Klumpp; John Koreth; Hillard M Lazarus; David I Marks; Rodrigo Martino; David A Rizzieri; Jacob M Rowe; Mitchell Sabloff; Edmund K Waller; John F DiPersio; Donald W Bunjes; Daniel J Weisdorf
Journal:  Blood       Date:  2010-06-10       Impact factor: 22.113

2.  Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remission.

Authors:  Armin Rashidi; Mehdi Hamadani; Mei-Jie Zhang; Hai-Lin Wang; Hisham Abdel-Azim; Mahmoud Aljurf; Amer Assal; Ashish Bajel; Asad Bashey; Minoo Battiwalla; Amer M Beitinjaneh; Nelli Bejanyan; Vijaya Raj Bhatt; Javier Bolaños-Meade; Michael Byrne; Jean-Yves Cahn; Mitchell Cairo; Stefan Ciurea; Edward Copelan; Corey Cutler; Andrew Daly; Miguel-Angel Diaz; Nosha Farhadfar; Robert P Gale; Siddhartha Ganguly; Michael R Grunwald; Theresa Hahn; Shahrukh Hashmi; Gerhard C Hildebrandt; H Kent Holland; Nasheed Hossain; Christopher G Kanakry; Mohamed A Kharfan-Dabaja; Nandita Khera; Yener Koc; Hillard M Lazarus; Jong-Wook Lee; Johan Maertens; Rodrigo Martino; Joseph McGuirk; Reinhold Munker; Hemant S Murthy; Ryotaro Nakamura; Sunita Nathan; Taiga Nishihori; Neil Palmisiano; Sagar Patel; Joseph Pidala; Rebecca Olin; Richard F Olsson; Betul Oran; Olov Ringden; David Rizzieri; Jacob Rowe; Mary Lynn Savoie; Kirk R Schultz; Sachiko Seo; Brian C Shaffer; Anurag Singh; Melhem Solh; Keith Stockerl-Goldstein; Leo F Verdonck; John Wagner; Edmund K Waller; Marcos De Lima; Brenda M Sandmaier; Mark Litzow; Dan Weisdorf; Rizwan Romee; Wael Saber
Journal:  Blood Adv       Date:  2019-06-25

3.  Allogeneic bone marrow transplantation for chronic myelogenous leukemia: comparative analysis of unrelated versus matched sibling donor transplantation.

Authors:  Daniel J Weisdorf; Claudio Anasetti; Joseph H Antin; Nancy A Kernan; Craig Kollman; David Snyder; Effie Petersdorf; Gene Nelson; Philip McGlave
Journal:  Blood       Date:  2002-03-15       Impact factor: 22.113

4.  High risk of graft failure in patients with anti-HLA antibodies undergoing haploidentical stem-cell transplantation.

Authors:  Stefan O Ciurea; Marcos de Lima; Pedro Cano; Martin Korbling; Sergio Giralt; Elizabeth J Shpall; Xuemei Wang; Peter F Thall; Richard E Champlin; Marcelo Fernandez-Vina
Journal:  Transplantation       Date:  2009-10-27       Impact factor: 4.939

5.  Myeloablative vs reduced intensity T-cell-replete haploidentical transplantation for hematologic malignancy.

Authors:  Scott R Solomon; Andrew St Martin; Nirav N Shah; Giancarlo Fatobene; Monzr M Al Malki; Karen K Ballen; Asad Bashey; Nelli Bejanyan; Javier Bolaños Meade; Claudio G Brunstein; Zachariah DeFilipp; Richard E Champlin; Ephraim J Fuchs; Mehdi Hamadani; Peiman Hematti; Christopher G Kanakry; Joseph P McGuirk; Ian K McNiece; Stefan O Ciurea; Marcelo C Pasquini; Vanderson Rocha; Rizwan Romee; Sagar S Patel; Sumithira Vasu; Edmund K Waller; John R Wingard; Mei-Jie Zhang; Mary Eapen
Journal:  Blood Adv       Date:  2019-10-08

6.  The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy.

Authors:  Craig Kollman; Stephen R Spellman; Mei-Jie Zhang; Anna Hassebroek; Claudio Anasetti; Joseph H Antin; Richard E Champlin; Dennis L Confer; John F DiPersio; Marcelo Fernandez-Viña; Robert J Hartzman; Mary M Horowitz; Carolyn K Hurley; Chatchada Karanes; Martin Maiers; Carlheinz R Mueller; Miguel-Angel Perales; Michelle Setterholm; Ann E Woolfrey; Neng Yu; Mary Eapen
Journal:  Blood       Date:  2015-11-02       Impact factor: 22.113

7.  Is a matched unrelated donor search needed for all allogeneic transplant candidates?

Authors:  Stefan O Ciurea; Maria Cecilia Borges Bittencourt; Denái R Milton; Kai Cao; Piyanuch Kongtim; Gabriela Rondon; Julianne Chen; Marina Konopleva; Jorge M Ramos Perez; Mohammed F El Shazly; Majdi Aljadayeh; Michele Alvarez; Jin Im; Gheath Al-Atrash; Rohtesh Mehta; Uday Popat; Qaiser Bashir; Betul Oran; Chitra M Hosing; Issa F Khouri; Partow Kebriaei; Richard E Champlin
Journal:  Blood Adv       Date:  2018-09-11

Review 8.  Post-transplant cyclophosphamide use in matched HLA donors: a review of literature and future application.

Authors:  Riad El Fakih; Shahrukh K Hashmi; Stephen O Ciurea; Leo Luznik; Robert Peter Gale; Mahmoud Aljurf
Journal:  Bone Marrow Transplant       Date:  2019-05-14       Impact factor: 5.483

9.  Alternative donor transplantation for acute myeloid leukemia in patients aged ≥50 years: young HLA-matched unrelated or haploidentical donor?

Authors:  Miguel-Angel Perales; Benjamin Tomlinson; Mei-Jie Zhang; Andrew St Martin; Amer Beitinjaneh; John Gibson; William Hogan; Natasha Kekre; Hillard Lazarus; David Marks; Joseph McGuirk; Rizwan Romee; Melhem Solh; John E Wagner; Daniel J Weisdorf; Marcos de Lima; Mary Eapen
Journal:  Haematologica       Date:  2020-01-31       Impact factor: 11.047

10.  Haploidentical stem cell transplantation (HaploSCT) for patients with acute leukemia-an update on behalf of the ALWP of the EBMT.

Authors:  Arnon Nagler; Annalisa Ruggeri
Journal:  Bone Marrow Transplant       Date:  2019-08       Impact factor: 5.483

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.